A Vienna-based researcher proposes shifting aging research from genome-focused studies to organelle resilience mechanisms, introducing the Comparative Metabolic Longevity Cell Atlas (CMLCA) platform. This cross-mammalian approach integrates standardized cellular systems with organelle-resolved multi-omics to identify conserved longevity features across species with divergent lifespans. The framework recognizes that cellular organelles—mitochondria, endoplasmic reticulum, and other subcellular structures—represent critical aging bottlenecks that genomic analysis alone cannot capture. This paradigm shift addresses a fundamental limitation in current longevity research: interventions that extend lifespan in laboratory organisms consistently fail to translate meaningfully to humans. The organelle-centric approach offers compelling biological logic since longer-lived mammals require sustained cellular machinery function over decades, not just genetic stability. This represents a potentially transformative methodological advance that could unlock novel healthspan interventions by focusing on the actual cellular components that fail with age. However, the success of this ambitious platform will depend on standardizing complex organelle analysis across diverse mammalian species and translating findings into actionable human therapies.